HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sunscreen monograph effective date delay

This article was originally published in The Rose Sheet

Executive Summary

FDA plans to publish notice further delaying effective date for sunscreen final monograph by the end of December, agency says in a recently-released meeting memorandum. The current compliance date is Dec. 31, 2002. During an Oct. 29 meeting with CTFA, the agency said it plans to postpone effective date and consider a number of issues raised by the association, memo notes. CTFA requested: elimination of limits on SPF claims; elimination of restrictions on anti-aging claims for sunscreens; broader selection of approved uses and directions; and relief from some labeling requirements for all sunscreens, skin protectants and antiperspirants...

You may also be interested in...



CTFA’s Supreme Court connection

Supreme Court nominee John Roberts maintains he failed to include prior lobbying work on behalf of the Cosmetic, Toiletry and Fragrance Association on a recent Senate questionnaire because his conversations with government attorneys at the time "were focused on the prospect of litigation" in Aug. 3 letter to Senate Judiciary Ranking Democrat Patrick Leahy (Vt.). Letter follows media reports Roberts neglected to list the stint. As an attorney with Hogan & Hartson in 2001, he was retained to help CTFA lobby FDA to change proposed labeling requirements in the OTC sunscreen final monograph, Roberts writes, adding he was "asked to prepare a legal analysis of how the proposed regulation would violate the First Amendment" and advise FDA the rule would trigger litigation. Roberts, former CTFA President Ed Kavanaugh and VP-Legal & General Counsel Tom Donegan attended an Oct. 29, 2001 meeting with FDA officials, after which the effective date for the sunscreen final rule was delayed (1"The Rose Sheet" Dec. 3, 2001, In Brief)...

DevaCurl Faces Multiple Class Actions As Latest Brand Linked To Hair Loss

The company maintains that its products are safe, but plaintiffs in proposed class actions allege it has knowingly put consumers at risk of hair loss and other injuries. DevaCurl’s troubles escalated quickly after a former brand ambassador went viral with a 31 January video urging consumers to stop using DevaCurl products and adopt safer alternatives.

Could ICER Outreach To US FDA Lead To Better Cost Effectiveness Analyses?

To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.

UsernamePublicRestriction

Register

RS009855

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel